| Bioactivity | Cefditoren is an orally active antibiotic with broad-spectrum antibacterial activity, capable of inhibiting both Gram-negative and Gram-positive bacteria. It has a MIC50 of 0.25-0.5 mg/L against Streptococcus pneumoniae strains. Cefditoren is effective against respiratory tract infections and skin infections[1][2][3]. |
| CAS | 104145-95-1 |
| Formula | C19H18N6O5S3 |
| Molar Mass | 506.58 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Cefditoren. 2023 Aug 15. [2]. Giuliano S, et al. Cefditoren: a clinical overview. New Microbiol. 2023 Feb;46(1):9-17. [3]. Sempere J, et al. A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain. J Antimicrob Chemother. 2022 Mar 31;77(4):1045-1051. |
Cefditoren
CAS: 104145-95-1 F: C19H18N6O5S3 W: 506.58
Cefditoren is an orally active antibiotic with broad-spectrum antibacterial activity, capable of inhibiting both Gram-ne
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.